Lessons learned after the withdrawal of rofecoxib.
Giaquinta
Diane
D
Department of Pharmacy Practice.
D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D003659:Decision Making, Organizational; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib